|
|
|
41
|
72416
|
MANGANESE 0.1 MG/ML INJ (KWA)
|
MANGANESE
|
MANGANESE
|
10ML
|
BQ
|
73.2045
|
73.2045
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4012
|
REPLACEMENT THERAPY
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
40
|
72517
|
COPPER 0.4 MG/ML INJ (KWA/ATB)
|
COPPER
|
COPPER
|
10ML
|
BQ
|
38.06
|
38.06
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4012
|
REPLACEMENT THERAPY
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
40
|
72712
|
CHROMIUM 4 MCG/ML INJ (KWA/ATB)
|
CHROMIUM
|
CHROMIUM
|
10ML
|
BQ
|
212.03
|
212.03
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4012
|
REPLACEMENT THERAPY
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
72712
|
CHROMIUM 4 MCG/ML INJ (KWA)
|
CHROMIUM
|
CHROMIUM
|
10ML
|
BQ
|
180.2249
|
180.2249
|
VIAL
|
30
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4012
|
REPLACEMENT THERAPY
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
REPLACEMENT THERAPY
|
|
|
|
|
42
|
72713
|
CHROMIUM 4MCG/ML INJ (KWA)
|
CHROMIUM
|
CHROMIUM
|
10ML
|
BQ
|
459.75
|
459.75
|
VIAL
|
0
|
|
KWA
|
KWALITY PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
4012
|
REPLACEMENT THERAPY
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
REPLACEMENT THERAPY
|
2026-03-02
|
|
|
|
40
|
72811
|
TOPAMAX 25MG TAB (JAC/STO) TOPIRAMATE
|
TOPIRAMATE
|
TOPAMAX
|
20'S
|
C
|
18.19
|
0.91
|
TABLET
|
0
|
TAB
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
72811
|
TOPAMAX 25MG TAB (JAC) TOPIRAMATE (C)
|
TOPIRAMATE
|
TOPAMAX
|
20'S
|
C
|
18.19
|
0.9093
|
TAB
|
60
|
BOX
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
72811
|
TOPAMAX 25MG TAB (JAC) TOPIRAMATE
|
TOPIRAMATE
|
TOPAMAX
|
20'S
|
C
|
18.19
|
0.91
|
TAB
|
60
|
BLIS
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
72812
|
APO-TOPIRAMATE 25MG TAB (APO/COL)
|
TOPIRAMATE
|
APO-TOPIRAMATE
|
100'S
|
BP
|
9.24
|
0.09
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
72812
|
APO-TOPIRAMATE 25MG TAB (APO)
|
TOPIRAMATE
|
APO-TOPIRAMATE
|
100'S
|
B
|
7.67
|
0.08
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
7281K
|
NEUROTOPREL 25MG TAB (ABB/PHA) TOPIRAMATE
|
TOPIRAMATE
|
NEUROTOPREL
|
30'S
|
C
|
20.12
|
0.67
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
7281K
|
NEUROTOPREL 25MG TAB (ABB/PHA) TOPIRAMATE (C)
|
TOPIRAMATE
|
NEUROTOPREL
|
30'S
|
C
|
20.12
|
0.6707
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
ANTICONVULSANTS MISCELLANEOUS
|
2023-03-02
|
|
|
|
41
|
7281L
|
TOPIRAMATE 25MG TAB (CAM) (BP)
|
TOPIRAMATE
|
TOPIRAMATE
|
60'S
|
BP
|
4.97
|
0.0829
|
TAB
|
60
|
BOTT
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
72831
|
TOPAMAX 100MG TAB (JAC/STO) TOPIRAMATE
|
TOPIRAMATE
|
TOPAMAX
|
20'S
|
C
|
58.55
|
2.93
|
TABLET
|
0
|
TAB
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
72831
|
TOPAMAX 100MG TAB (JAC) TOPIRAMATE (C)
|
TOPIRAMATE
|
TOPAMAX
|
20'S
|
C
|
58.55
|
2.9276
|
TAB
|
120
|
BOX
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
72831
|
TOPAMAX 100MG TAB (JAC) TOPIRAMATE
|
TOPIRAMATE
|
TOPAMAX
|
20'S
|
C
|
58.55
|
2.93
|
TAB
|
120
|
BLIS
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
72833
|
APO-TOPIRAMATE 100MG TAB (APO/COL)
|
TOPIRAMATE
|
APO-TOPIRAMATE
|
100'S
|
BP
|
16.66
|
0.17
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
72833
|
APO-TOPIRAMATE 100MG TAB (APO)
|
TOPIRAMATE
|
APO-TOPIRAMATE
|
100'S
|
BP
|
16.99
|
0.17
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
41
|
7283G
|
TOPIRAMATE 100MG TAB (CIP) (BP)
|
TOPIRAMATE
|
TOPIRAMATE
|
60'S
|
BP
|
9.49
|
0.1581
|
TAB
|
120
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2025-03-10
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
2025-01-27
|
|
|
|
40
|
7283Q
|
NEUROTOPREL 100MG TAB (ABB/PHA) TOPIRAMATE
|
TOPIRAMATE
|
NEUROTOPREL
|
30'S
|
C
|
73.12
|
2.44
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|